KYBELLA® is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness a.k.a “double chin.”
KYBELLA® is the first FDA approved non-surgical treatment for improving the appearance of moderate to severe submental fullness, commonly referred to as double chin. KYBELLA® is a non-human and non-animal formulation of deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into subcutaneous fat, KYBELLA® causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.
KYBELLA® (deoxycholic acid) injection 10 mg/mL is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
KYBELLA is administered by a trained healthcare professional who injects the product under a patient’s chin to destroy fat cells, improving the appearance of the patient’s chin area. Up to six treatments may be administered per patient no less than six weeks apart, and each in-office treatment session lasts less than one hour.